Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Atrium Therapeutics, Inc. company logo
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA)

Summary

As of today, RNA price is $13.25, up +4.41% in the most recent trading session on
RNA price is currently -20.99% below its historical high of $16.77 set on
RNA current market cap is $2B, with unknown 1-year change
RNA PE ratio is unknown
RNA current annual revenue is $18.76M, up +72.11% year-over-year
The next earnings release for RNA is on

Profile

Company profile for Atrium Therapeutics, Inc. (RNA)
MetricValue
Full NameAtrium Therapeutics, Inc.
TickerNASDAQ: RNA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteaviditybiosciences.com
Employees391

Key Metrics

Atrium Therapeutics, Inc. Key Details
MetricDateValue
Price$13.25
Price, 1D Change+4.41%
Market Cap$2B
-
PE Ratio-
Beta2.80
Revenue$19M
Revenue, 1Y Change+72.11%
EPS-$4.97
EPS, 1Y Change-72.11%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Atrium Therapeutics, Inc. chart

Events

Atrium Therapeutics, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

RNA Estimates
MetricDateValue
EPS-$4.97
EPS EstimateN/A-$4.92
EPS Est. ChangeN/A+1.03%
Revenue$18.76M
Revenue EstimateN/A$19.34M
Revenue Est. ChangeN/A+3.10%
Current Price$13.25
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

RNA EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$2.74-$2.91-6.08%
-$2.86-$2.89-1.09%
-$4.49-$4.97-10.62%
-$4.92N/A+1.03%
RNA EPS reported versus estimate values chart

Revenue

RNA revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$9.56M$9.56M0.00%
$9.75M$10.90M+11.76%
$18.36M$18.76M+2.16%
$19.34MN/A+3.10%
RNA revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

RNA Performance
MetricDateValue
Price, 1Y-
Price, 3Y-
Market Cap, 1Y-
Market Cap, 3Y-
Revenue, 1Y+72.11%
Revenue, 3Y+103.33%
EPS, 1Y-72.11%
EPS, 3Y-49.04%

🔒 Log In To Unlock Full Data

Technical Indicators

RNA Technical Indicators
MetricDateValue
Current Price$13.25
SMA 200$14.49
SMA 200 vs Price+9.32%
SMA 50$14.49
SMA 50 vs Price+9.32%
Beta2.80
ATR$0.69
14-Day RSI28.90
10-Day Volatility61.70%
1-Year Volatility70.75%

Dividends

RNA Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

RNA Income & Profitability
MetricDateValue
Revenue$18.76M
EPS-$4.97
Gross Profit$14.60M
Gross Margin77.87%
Operating Profit-$745.94M
Operating Margin-3,977.30%
Net Income-$684.63M
Net Margin-3,650.39%
EBITDA-$741.79M

🔒 Log In To Unlock Full Data

Financial Health

RNA Financial Health
MetricDateValue
Debt To Equity0.03
9.20
9.20
-
1
3.05

Valuations

RNA Valuations
MetricDateValue
PE Ratio-
106.45
1.18
-0.47
N/A-

Balance Sheet

RNA Balance Sheet
MetricDateValue
Book Value$1.69B
$1.70B
$1.96B
$1.80B
$269.45M
$195.45M
Total Debt$49.25M
$3.94M
$12.40M

Expenses

RNA Expenses
MetricDateValue
$703.39M
$760.55M
$4.15M
$0.00
$4.15M
$0.00
$0.00

Cash Flow

RNA Cash Flow
MetricDateValue
-$650.44M
-$38.04M
$850.99M
Capex$13.32M
-$663.76M

Recent analyst updates

RNA Recent analyst updates
MetricDateValue
Chardan Capital→
TD Cowen→
RBC Capital→
Chardan Capital→
Raymond James→
Needham→
Leerink Partners→
HC Wainwright & Co.→
Citigroup→
Bernstein→

Analyst sentiment

Sentiment over the past month
RNA analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
RNA institutional ownership distribution chart

Screeners with RNA

FAQ

  • What is the ticker symbol for Atrium Therapeutics, Inc.?

    The ticker symbol for Atrium Therapeutics, Inc. is NASDAQ:RNA

  • Does Atrium Therapeutics, Inc. pay dividends?

    No, Atrium Therapeutics, Inc. does not pay dividends

  • What sector is Atrium Therapeutics, Inc. in?

    Atrium Therapeutics, Inc. is in the Healthcare sector

  • What industry is Atrium Therapeutics, Inc. in?

    Atrium Therapeutics, Inc. is in the Biotechnology industry

  • What country is Atrium Therapeutics, Inc. based in?

    Atrium Therapeutics, Inc. is headquartered in United States

  • When did Atrium Therapeutics, Inc. go public?

    Atrium Therapeutics, Inc. initial public offering (IPO) was on June 12, 2020

  • Is Atrium Therapeutics, Inc. in the S&P 500?

    No, Atrium Therapeutics, Inc. is not included in the S&P 500 index

  • Is Atrium Therapeutics, Inc. in the NASDAQ 100?

    No, Atrium Therapeutics, Inc. is not included in the NASDAQ 100 index

  • Is Atrium Therapeutics, Inc. in the Dow Jones?

    No, Atrium Therapeutics, Inc. is not included in the Dow Jones index

  • When was Atrium Therapeutics, Inc. last earnings report?

    Atrium Therapeutics, Inc.'s most recent earnings report was on March 2, 2026

  • When does Atrium Therapeutics, Inc. report earnings?

    The next expected earnings date for Atrium Therapeutics, Inc. is May 11, 2026

Data Sources & References

  1. RNA Official Website www.aviditybiosciences.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
  4. RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
  5. RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna